rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0005064,
umls-concept:C0024554,
umls-concept:C0026056,
umls-concept:C0031327,
umls-concept:C0670249,
umls-concept:C0681850,
umls-concept:C0851347,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1707455,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
5
|
pubmed:dateCreated |
1998-2-11
|
pubmed:abstractText |
This study aimed to investigate the pharmacodynamics and pharmacokinetics of ascending doses of Ro 48-8684, compared with midazolam, in healthy subjects during first administration to man.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0306-5251
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
487-93
|
pubmed:dateRevised |
2009-10-2
|
pubmed:meshHeading |
pubmed-meshheading:9384466-Adult,
pubmed-meshheading:9384466-Anti-Anxiety Agents,
pubmed-meshheading:9384466-Benzodiazepines,
pubmed-meshheading:9384466-Cross-Over Studies,
pubmed-meshheading:9384466-Dose-Response Relationship, Drug,
pubmed-meshheading:9384466-Double-Blind Method,
pubmed-meshheading:9384466-Electroencephalography,
pubmed-meshheading:9384466-Humans,
pubmed-meshheading:9384466-Infusions, Intravenous,
pubmed-meshheading:9384466-Male,
pubmed-meshheading:9384466-Midazolam,
pubmed-meshheading:9384466-Oxazoles,
pubmed-meshheading:9384466-Placebos,
pubmed-meshheading:9384466-Saccades
|
pubmed:year |
1997
|
pubmed:articleTitle |
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects.
|
pubmed:affiliation |
Centre for Human Drug Research, Leiden, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|